These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 738079)

  • 1. In vitro activity of oxolinic acid and nalidixic acid against common urinary pathogens: a comparative study.
    de Rautlin de la Roy Y; Toma V; Bobin B
    Curr Med Res Opin; 1978; 5(9):743-8. PubMed ID: 738079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro action of oxolinic acid in comparison with nitrofurantoin and nalidixic acid].
    Grima P
    Minerva Urol; 1977; 29(5):225-7. PubMed ID: 611403
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibacterial activity of miloxacin.
    Izawa A; Kisaki Y; Irie K; Eda Y; Nakagome T; Komatsu T
    Antimicrob Agents Chemother; 1980 Jul; 18(1):37-40. PubMed ID: 7416749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethoprim enhances the antibacterial activity of nalidixic and oxolinic acids and delays the emergence of resistance.
    Bertolini A; Castelli M; Genedani S; Garuti M
    Experientia; 1980 Feb; 36(2):243-4. PubMed ID: 7371772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative studies of the effect of oxolinic and nalidixic acids on urinary flora].
    Balog F; Këvesh SH; Kochish B
    Urol Nefrol (Mosk); 1974; (6):25-8. PubMed ID: 4446181
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of antibacterial activity of oxolinic acid (Gramurin) and nalidixic acid (Nevigramon) in vitro and in patients with urinary tract infections].
    Manitius A; Hebanowski M; Galiński J; Nowicki B
    Pol Tyg Lek; 1978 Aug; 33(34):1347-50. PubMed ID: 704439
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Oxolinic acid in urinary infections.
    Grüneberg RN
    Lancet; 1974 Nov; 2(7888):1088-9. PubMed ID: 4138360
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative in vitro studies of nalidixic acid, oxolinic acid, and a new analog with thieno (2,3-b) pyridine structure.
    Gilis PM; Haemers A; Pattyn SR
    Antimicrob Agents Chemother; 1978 Mar; 13(3):533-5. PubMed ID: 263890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids.
    Greenwood D
    Antimicrob Agents Chemother; 1978 Mar; 13(3):479-83. PubMed ID: 400825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross resistance of quinolone derivatives in gram-negative bacteria.
    Barba D; Pennucci C; Esposito S; Galante D
    Chemioterapia; 1985 Apr; 4(2):192-6. PubMed ID: 3159488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the antibacterial effects of ofloxacin, oxolinic acid and nalidixic acid].
    Langsádl L; Menkyna R; Golier J; Silan L
    Cesk Epidemiol Mikrobiol Imunol; 1988 Sep; 37(5):297-308. PubMed ID: 3197127
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R; Allocati N; Catamo G
    Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Minimal inhibitory concentration in hospital bacteria].
    Marcenac FM; Fernández AJ; Rebollo MN; Helou HT; Civalero TR; Herran IL; Magri MA
    Rev Asoc Argent Microbiol; 1974; 6(2):44-61. PubMed ID: 4467221
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro investigations with oxolinic acid, a new chemotherapeutic agent.
    Neussel H; Linzenmeier G
    Chemotherapy; 1973; 18(4):253-61. PubMed ID: 4633010
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary tract infection treated with oxolinic acid.
    Pearson BS
    Med J Aust; 1975 Feb; 1(5):140-1. PubMed ID: 805351
    [No Abstract]   [Full Text] [Related]  

  • 16. [A comparison of the effects of three urinary infection chemotherapeutics - nalidixic, oxolinic, and pipemidic acids (author's transl)].
    Langsádl L; Polívková-Konícková L; Roubínek F
    Cas Lek Cesk; 1979 May; 118(19):588-92. PubMed ID: 498218
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the in vitro activity of flumequine on bacterial strains recently isolated in the hospital].
    Nani E; Amato G; Anzivino D; Covelli I
    Boll Ist Sieroter Milan; 1986; 65(1):14-21. PubMed ID: 3718678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of gram negative bacteria in midstream bladder urine and their sensitivity to quinoline derivatives.
    Esposito S; Galante D; Pennucci C; Barba D
    Microbiologica; 1985 Jul; 8(3):269-76. PubMed ID: 3162081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility comparisons and recommendations for oxolinic acid.
    Klein D; Matsen JM
    Antimicrob Agents Chemother; 1976 Apr; 9(4):649-54. PubMed ID: 1267439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.